The Indonesian Drug and Food Control Agency (BPOM) said it will penalize two pharmaceutical companies after ethylene glycol (EG) and diethylene glycol (DEG) were detected in their syrups.
More than 400,000 links to advertised medicines that had yet to meet the requirements have been taken down.
Ministry of Health has announced that Sinovac vaccine will be used as a COVID-19 booster shot.
Earlier this month, the United Kingdoms Food Standards Agency (FSA) issued a statement that advised consumers not to eat certain Kinder products in connection with potential link to salmonella outbreak.
Volunteers taking part in Merah Putih vaccine trial will be monitored for a year after they received the shot.
All subjects must be at least 18 years of age, and the phase one trial is planned to be carried out on February 9 at Regional Public Hospital (RSUD) Dr. Soetomo in Surabaya, East Java.
BPOM issues emergency use authorization (UEA) upon evaluation on the safety and efficacy aspects of Sinopharm vaccine, which will be used as homologous booster.
Merah Putih vaccine has concluded its preclinical trial on animal and is currently awaiting phase one of clinical trial planned for early February.
The Agency issued emergency use authorization (UEA) after evaluation with experts found the vaccines to have met the standards and requirements.
